Amevive Related Clinical Trials
Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Recruiting]
AMEVIVE� Pregnancy Registry [Recruiting]
Long-Term One Year Use of Alefacept (Amevive�) in Moderate to Severe Chronic Plaque Type Psoriasis [Recruiting]
Inducing Remission in Type 1 Diabetes With Alefacept [Recruiting]
Community Based Trial for AMEVIVE® [Completed]
Alefacept for Prevention of Graft Versus Host Disease (GVHD) [Recruiting]
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia [Recruiting]
Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis. [Completed]
Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis [Recruiting]
Alefacept in Kidney Transplant Recipients [Not yet recruiting]
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease [Recruiting]
A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus [Suspended]
Alefacept Mechanism of Action in Psoriasis [Active, not recruiting]
Open-Label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis [Completed]
A Placebo-Controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis [Completed]
Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients [Completed]
Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-Treated Adults With Chronic Plaque Psoriasis [Active, not recruiting]
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects [Recruiting]
A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate [Completed]
A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis [Completed]
Alefacept for Chronic Graft Versus Host Disease [Recruiting]
A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers [Recruiting]
Transitioning From Cyclosporine to Alefacept in Psoriasis [Active, not recruiting]
Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis [Recruiting]
Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis [Recruiting]
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients [Recruiting]
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris [Recruiting]
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation [Recruiting]
Safety and Tolerability of Repeat Courses of IM Alefacept [Completed]
Alefacept in Patients With Severe Scalp Alopecia Areata [Completed]
A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients [Recruiting]
Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis [Completed]
Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.Eâ„¢) Program [Recruiting]
Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis [Completed]
A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients [Recruiting]
Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma [Recruiting]
Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment [Completed]
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer [Completed]
Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer [Active, not recruiting]
Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) [Recruiting]
Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Completed]
Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva) [Completed]
Vaccine Therapy in Treating Patients With Metastatic Melanoma [Active, not recruiting]
|
